HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
NX-1207
Description
NX-1207 is an investigational new drug for BPH, whose chemical entity and mechanism of action remain undisclosed. Nymox Pharmaceutical Corporation recently completed studies of NX-1207 for treatment of benign prostatic hyperplasia (BPH).
No brand information found.
